Sayak Banerjee, Amity University Kolkata Migraine and its chronification: Migraine is a significant primary headache disorder as it ranks the sixth most prevailing disease and the second cause of disability worldwide. This widespread neurological disease is distinguished by headaches which might take place with or without aura. An aura is a kind of sensory disturbance […]
Soumya Shraddhya Paul, Amity University Noida For a very long time, monoclonal antibodies have been used in various fields (cancer studies) but currently, they are being used to counteract the effects of SARS-CoV-2 and its variant by being an active compound in the vaccine as well as therapeutic drugs. Hence, to understand B cell genomics […]
Arpan Banerjee, University of Calcutta Since the time Covid-19 has plagued the entire world, many studies have evolved emphasizing its heterogeneous clinical presentation, ranging from silent asymptomatic carriers to the severe ones bogged down with respiratory failure. The clinical trials about the finding of the wonder drug is still awaited. In the meantime, several drugs […]
Surupa Chakraborty, Amity University Kolkata The U.S. Food and Drug Administration recently approved Inmazeb, a potent treatment involving a cocktail of three lab-made monoclonal antibodies (atoltivimab, maftivimab, and odesivimab-ebgn) to fight against Ebola, one of the world’s deadliest diseases known so far. Inmazeb targets the glycoprotein, which latches onto the cell surface receptors and fuses […]
Sayak Banerjee, Amity University Kolkata Many a time, a heart transplant is the only hope of survival for patients with any cardiac problems when every other surgery fails. For this, they have to wait for too long. Cardiac xenotransplantation has been a target of scientists globally for years, and in one year, pig hearts might […]
PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Hybridoma Technology is known for its’ large-scale production of identical antibodies. Recently, the European Commission’s Joint Research Centre (EC-JRC) urged the government to allow the development of animal-free antibodies for the production of vaccine development. This came after the work done by the Scientific Advisory Committee (ESAC) and claims were […]
